Mass spectrometry imaging identifies abnormally elevated brain l-DOPA levels and extrastriatal monoaminergic dysregulation in l-DOPA–induced dyskinesia

l-DOPA treatment for Parkinson’s disease frequently leads to dyskinesias, the pathophysiology of which is poorly understood. We used MALDI-MSI to map the distribution of l-DOPA and monoaminergic pathways in brains of dyskinetic and nondyskinetic primates. We report elevated levels of l-DOPA, and its...

Descripción completa

Detalles Bibliográficos
Autores principales: Fridjonsdottir, Elva, Shariatgorji, Reza, Nilsson, Anna, Vallianatou, Theodosia, Odell, Luke R., Schembri, Luke S., Svenningsson, Per, Fernagut, Pierre-Olivier, Crossman, Alan R., Bezard, Erwan, Andrén, Per E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787486/
https://www.ncbi.nlm.nih.gov/pubmed/33523980
http://dx.doi.org/10.1126/sciadv.abe5948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787486/
https://www.ncbi.nlm.nih.gov/pubmed/33523980
http://dx.doi.org/10.1126/sciadv.abe5948

Ejemplares similares